William D Barbo is Corporate Executive VP & CCO of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 3,433 shares of CRL, which is worth approximately $645,060. The most recent transaction as insider was on Jan 28, 2022, when has been sold 4,095 shares (Common Stock) at a price of $312.24 per share, resulting in proceeds of $1,278,623. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.43K
0% 3M change
4.43% 12M change
Total Value Held $645,060

William D Barbo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 28 2022
SELL
Payment of exercise price or tax liability
$1,278,623 $312.24 p/Share
4,095 Reduced 27.96%
10,549 Common Stock
Jan 28 2022
BUY
Grant, award, or other acquisition
-
10,273 Added 41.23%
14,644 Common Stock
Aug 06 2021
SELL
Open market or private sale
$5,012,771 $404.68 p/Share
12,387 Reduced 73.92%
4,371 Common Stock
Aug 06 2021
BUY
Exercise of conversion of derivative security
$1,080,152 $144.56 p/Share
7,472 Added 30.84%
16,758 Common Stock
Jun 09 2021
SELL
Bona fide gift
-
252 Reduced 5.45%
4,371 Common Stock
May 29 2021
SELL
Payment of exercise price or tax liability
$67,936 $337.99 p/Share
201 Reduced 4.17%
4,623 Common Stock
May 28 2021
BUY
Grant, award, or other acquisition
-
1,006 Added 17.26%
4,824 Common Stock
Mar 01 2021
SELL
Open market or private sale
$1,013,319 $290.1 p/Share
3,493 Reduced 47.78%
3,818 Common Stock
Mar 01 2021
BUY
Exercise of conversion of derivative security
$307,559 $88.05 p/Share
3,493 Added 32.33%
7,311 Common Stock
Feb 25 2021
SELL
Bona fide gift
-
1,157 Reduced 23.26%
3,818 Common Stock
Feb 24 2021
SELL
Payment of exercise price or tax liability
$91,120 $282.98 p/Share
322 Reduced 6.08%
4,975 Common Stock
Feb 23 2021
SELL
Payment of exercise price or tax liability
$89,331 $283.59 p/Share
315 Reduced 5.61%
5,297 Common Stock
Feb 22 2021
SELL
Payment of exercise price or tax liability
$83,101 $289.55 p/Share
287 Reduced 4.87%
5,612 Common Stock
Feb 04 2021
SELL
Bona fide gift
-
7,154 Reduced 54.81%
5,899 Common Stock
Feb 02 2021
SELL
Payment of exercise price or tax liability
$1,228,223 $260.88 p/Share
4,708 Reduced 26.51%
13,053 Common Stock
Feb 02 2021
BUY
Grant, award, or other acquisition
-
11,862 Added 40.04%
17,761 Common Stock
Mar 23 2020
SELL
Bona fide gift
-
12,151 Reduced 67.32%
5,899 Common Stock
WDB

William D Barbo

Corporate Executive VP & CCO
Wilmington, MA

Track Institutional and Insider Activities on CRL

Follow CHARLES RIVER LABORATORIES INTERNATIONAL, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Track Activities on CRL